Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

ACE inhibitors show promise in Alzheimer's disease

Oct. 20, 2004

Phase III findings on Ampligen for chronic fatigue syndrome

Oct. 20, 2004

Pramipexole for Parkinson's disease returns to Boehringer Ingelheim

Oct. 20, 2004

PBT-1 to enter phase II/III study in 2005

Oct. 20, 2004

Rivastigmine reported to improve cognition in schizophrenic patients

Oct. 20, 2004

Provid scientists present new MHC binding modulators for multiple sclerosis and other disorders

Oct. 20, 2004

New subunit-selective GABA-A receptor ligands developed at Merck

Oct. 20, 2004

RPI-78M successfully completes studies in MS animal model

Oct. 19, 2004

UCB Pharma in Parkinson's collaboration with Brigham and Women's Hospital

Oct. 19, 2004

Positive phase III results for Neupro in advanced Parkinson's

Oct. 19, 2004

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...